UWorld 1 Flashcards

1
Q

What arrhythmia is most specific for digitalis toxicity?

A

Atrial tachycardia with AV Block

Digitalis can increase ectopy in the atria or ventricles, which can lead to atrial tachycardia. Atrial tachycardia is distinguished from atrial flutter by its somewhat slower atrial rate (150-250 as opposed to 250-350).

P waves are present, but may appear different from p waves normally seen when conduction originates in SA node. In atrial tachy, the closer the ectopic focus is to the SA node, the closer the resemblance of its p waves to normal p waves coming from the SA node.

In addition to causing ectopic rhythms, digitalis can also increase vagal tone and decrease conduction through the AV node, potentially causing AV block. Since it is so rare for atrial tachy and AV block to occur at the same time, seeing them together is pretty specific for digitalis toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does digitalis cause AFib?

A

It doesn’t. In fact, it increases vagal tone and can be used to sometimes treat AFib if B-blockers or CCBs have not been completely effective.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Multifocal atrial tachycardia is often associated with dysfunction in which organ system?

A

Pulmonary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

RV MI

A

30-50% of patients with acute inferior wall MI due to occlusion of RCA proximal to the origin of the RV branches.

Chest pain, autonomic signs and ECG findings of ST elevation in inferior leads II, III, and aVF.

May also have JVD and Kussmaul’s sign (increase in JVD with inspiration) along with clear lung fields, which are suggestive of RV failure.

Transient bradycardia or AV block can also occur with acute inferior MI due to enhanced vagal tone.

Dx is confirmed with at least 1mm ST elevation in R sided precordial leads V4R-V6R. RV failure leads to decreased preload and resultant hypotension. Therefore, in addition to standard MI therapy, such patients (without pulm congestion) are typically treated with bolus of IVFs (isotonic saline) to improve RV preload and help LV filling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

IV septum rupture

A

Can lead to L-R shunt, which increases strain on RV and can result in RV failure. These patients usually have a loud holosystolic murmur on exam.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pulm embolism on ECG

A

Tachycardia, nonspecific ST segment or T wave changes, new onset RBBB or S1Q3T3 pattern.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What drugs should be avoided in RV MI?

A

These patients are preload dependent, so avoid diuretics and nitrates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

STEMI management

A

1) O2 for arterial saturation less than 90
2) Nitrates - caution with hypotension, RV infarct, or severe aortic stenosis
3) Antiplatelets - Aspirin plus P2Y12 receptor blocker
4) Anticoagulation - unfractionated heparin, low molecular weight heparin, or bivalirudin
5) B blockers - contraindicated in overt HF; high risk for cardiogenic shock; bradycardia
6) Prompt reperfusion with PCI - ideal first medical contact for PCI in less than 90 minutes
7) Statin therapy ASAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Crescendo-decrescendo systolic murmur along with left sternal border without carotid radiation in a young patient

A

This is the murmur of HOCM (hypertrophic obstructive cardiomyopathy), which is IV septal hypertrophy.

Common symptoms include syncope, dyspnea, and CP.

Syncope in HOCM is multifactorial. In large part, it’s due to outflow obstruction from the hypertrophied myocardium. But, syncope can also be secondary to arrhythmia, ischemia, and a ventricular baroreceptor response that inappropriately causes vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

History of recent URI followed by sudden onset of cardiac failure in an otherwise healthy patient

A

Suggests dilated cardiomyopathy, most likely secondary to acute viral myocarditis.

Dilated cardiomyopathy is the end result of myocardial damage produced by a variety of toxic, metabolic, or infectious agents. Viral or idiopathic myocarditis is most commonly seen after Coxsackie B infection and occurs in about 3.5-5% of infected patients.

Other viruses commonly implicated include ParvoB19, HHV6, adenovirus, and enterovirus.

Viral myocarditis can cause dilated cardiomyopathy via direct viral damage and as a result of humoral or cellular immune responses to persistent viral infections.

The dx of dilated cardiomyopathy is made by Echo. It shows dilated ventricles with diffuse hypokinesia resulting in a low EF (systolic dysfunction). Tx is largely supportive involving mainly the management of CHF symptoms

Always think dilated cardiomyopathy in the acute heart failure patient. The other types take time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Use Dependence

A

Refers to enhanced pharm effects of a drug during faster HRs and is seen with class I (esp in class 1C - Flecainide and propafenone) and IV (CCBs).

Class 1 antiarrhythmics block sodium channels and inhibit depolarization phase (phase 0) of AP.

IC drugs are occasionally used in tx of AFib (for maintenance of sinus rhythm) in patients with structurally normal hearts. They have the slowest rate of drug binding and dissociation from the sodium channel receptor. Under normal circumstances, flecainide does not cause any QRS or QT prolongation

BUT

In patients with faster heart rates, the drug has less time to dissociate from the sodium channels, leading to higher number of blocked channels. This leads to progressive decrease in impulse conduction and widening of QRS complex. This phenomenon is what is called Use Dependence. Seen most in Class 1C (less with 1A and rarely with 1B) and is the mechanism behind their efficacy against supraventricular arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Digoxin mechanism

A

Inhibits ATPase-dependent Na-K pump and increases intracellular Na. This reduces Na-Ca exchanger activity, resulting in an increase in intracellular Ca.

It also enhances vagal tone and slows conduction through the AV node. These effects can cause bradyarrhythmias (younger, healthier patients) or enhance automaticity and delayed after-depolarization leading to ventricular ectopy and tachyarrhythmias (more common in older patients with underlying cardiac diseases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Combo of exertional dyspnea, dry cough, and holosystolic murmur are most suggestive of what?

A

Mitral regurgitation. Exertional dyspnea and fatigue are common symptoms which are secondary to combo of lower CO and increased LA pressure.

Dry cough may relate to pulmonary congestion and edema. Indicates more severe disease that has resulted in LV dysfunction

Other common features are AFib and signs of HF.

MR murmur is holosystolic heard best over apex with radiation to axilla.

MR can occur as result of primary mitral valve diseases (RHD, infective endocarditis, trauma) or may be associated with other cardiac conditions (ischemic heart disease or hypertrophic cardiomyopathy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CHA2-DS2-VASc Score

A

1) CHF - 1
2) HTN - 1
3) Age 75 and up - 2
4) DM -1
5) Stroke/TIA/thromboembolism - 2
6) Vascular disease (prior MI, peripheral artery disease or aortic plaque) -1
7) Age 65-74 - 1
8) Sex category (female) -1

Max score is 9.

Score of 0 - low stroke risk. No antrithrombotic therapy needed.

Score 1 - intermediate. None or ASA or oral anticoagulants. Oral anticoagulants are preferred.

Score 2 and up - high. Oral anticoagulants.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lone AF

A

Patients with paroxysmal, persistent, or permanent AF with no evidence of cardiopulmonary or structural heart disease. These patients are usually less than 60 years old. By definition, their CHA2DS2VASc score is 0. Anticoagulant therapy is not needed.

Note: this is for nonvalvular AFib (as is the CHA2DS2VASc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acute limb ischemia

A

6 P’s

1) Pain
2) Pallor
3) Poikilothermia (cool extremity)
4) Paresthesia
5) Pulselessness
6) Paralysis

Most likely due to thromboembolic occlusion from L atrial thrombus due to AFib in a patient with preexisting peripheral vascular disease (multiple risk factors, intermittent claudication, diminished pulses).

Patients with suspected acute arterial occlusion leadng to an immediately threatened limb (sensory loss, rest pain, muscle weakness) should be immediately started on anticoagulation while further diagnostic procedures are done. Heparin prevents further thrombus propagation and thrombosis in the distal arterial and venous circulation. Put them on the drug first THEN confirm with arterial doppler study or duplex US.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Clinical features of cocaine use

A

Clinical

1) Sympathetic hyperactivity - tachycardia, HTN, dilated pupils
2) CP due to coronary vasoconstriction
3) Psychomotor agitation, seizures

Complications

1) Acute MI
2) Aortic dissection
3) Intracranial hemorrhage

Management of chest pain

1) IV Benzos* for BP and anxiety
2) Aspirin
3) Nitroglycerin and CCBs for pain
4) B blockers are CONTRAINDICATED
* (cause unopposed alpha blockade and worsen coronary vasoconstriction)
5) Fibrinolytics not preferred due to higher risk of ICH
6) Immediate cardiac cath with reperfusion when indicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cocaine mechanism

A

It potentiates sympathomimetic actions by causing inhibition of NE reuptake into the sympathetic neuron. This causes stimulation of alpha and beta adrenergic receptors and can result in coronary vasoconstriction and increase in HR, systemic BP, and myocardial O2 demand.

It also enhances thrombus formation by promoting platelet activation and aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Thoracic aortic aneurysm presentation

A

Look at the CXR. Shows mediastinal widening, increased aortic knob, and tracheal deviation. However, CXR cannot always distinguish TAA from tortuous aorta so get CT with contrast to confirm dx.

TAA can be ASx or present with chest, back, flank or abdominal pain depending on location.

Ascending aortic aneurysm (60%) starts anywhere from aortic valve to the innominate artery. Often due to cystic medial necrosis (usually occurs with aging) or connective tissue disorders (Marfan, Ehler-Danlos)

Descending arise distal to L subclavian. Usually due to atherosclerosis**. Risk factors include HTN, hypercholesterolemia, and smoking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Electrical alternans

A

Think pericardial effusion. Recent URI is a clue since pericardial effusions are often secondary to viral pericarditis. Accompanying pleural effusions may be found as well. Enlargement of cardiac silhouette can also be seen on CXR.

Electrical alternans describes QRS complexes whose amplitudes vary from beat to beat on EKG. It is thought to be from heart’s swinging back and forth in an increased quantity of pericardial fluid.

Look out! JVD, muffled heart sounds and borderline BP indicate developing tamponade.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Causes of HF with preserved LV function

A

Diastolic HF

1) HTN with LVH
2) Restrictive cardiomyopathy
3) Infiltrative cardiomyopathy (sarcoid)
4) Hypertrophic cardiomyopathy
5) Occult CAD

Valves

1) AS or AR
2) MS or MR

Pericardial disease

1) Constrictive pericarditis
2) Cardiac tamponade

Systemic disorders (high output cardiac conditions)

1) Thyrotoxicosis
2) Severe anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Exertional dyspnea, orthopnea (choking sensation/dyspnea when lying flat), bibasilar rales, lower extremity edema, and normal EF on Echo

A

HFpEF (diastolic dysfunction) - remember that LV can be normal or increased in size on echo here

Patients have typical signs of CHF (exertional dyspnea, orthopnea, lower extremity edema) but normal or near normal LV EF (over 50%) with objective evidence of diastolic dysfunction (abnormal LV filling pressures) by Echo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What causes diastolic dysfunction?

A

It is caused by impaired myocardial relaxation!!! Or by increased LV wall stiffness (lower compliance) leading to increased LV End-Diastolic Pressure.

The increase in LVEDP is transmitted to the LA and pulmonary veins and capillaries, causing pulm congestion, dyspnea, and exercise intolerance

This is made worse by the loss of the atrial kick and short diastolic filling times in patients who develop AFib (look for a patient with palpitations and irregularly irregular HR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What does Cor Pulmonale refer to?

A

Impaired RV function due to pulm HTN that occurs as a result of underlying pulmonary disease (COPD, Pulm vasculature disease, OSA). RV dysfunction would be seen on echo and would not cause bibasilar crackles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

High output heart failure can occur in what conditions?

A

1) Severe anemia
2) Hyperthyroid
3) Beriberi (B1/Thiamine def)
4) Paget Disease
5) AV fistula

High output is defined as a high cardiac output. Look for a cardiac index beyond normal range of 2.5 to 4L.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is a feared complication of acute aortic dissection?

A

Cardiac Tamponade.

Look for sudden onset of severe chest pain radiating to the back and widened mediastinum on CXR (aortic dissection)

Hypotension, JVD, and respiratory variation in systolic BP (pulsus paradoxus) - this suggests cardiac tamponade

CT is a complication with rupture of aorta and rapid accumulation of blood in pericardial space. Abrupt accumulation of even small amounts of blood can significantly raise the pressure inside the pericardial cavity. Increased pericardial pressure causes compression of cardiac chambers and limits diastolic filling of the right sided chambers. This causes lower preload and reduced CO, resulting in hypotension and syncope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Syncope associated with AS

A

Usually occurs with activity. CP is also typically exertional (not as severe as in aortic dissection).

You see pulsus parvus et tardus (slow rising and low amplitude pulse)

28
Q

Syncope due to tamponade vs volume loss

A

Flat neck veins in intravascular volume loss.

29
Q

Vasovagal syncope

A

Vagal hyperactivity is mechanism. Characterized by prodromal symptoms like dizziness, nausea, diaphoresis, pallor, and visual disturbances prior to syncope.

30
Q

Features of acute RVMI

A

Seen in 30-50% Acute STEMI of inferior wall. Due to occlusion of RCA proximal to origin of RV branches.

Features:

1) Symptoms of myocardial injury (CP, diaphoresis, dyspnea)
2) Hypotension (due to lower L Heart filling)
3) JVD (bc of RV dysfunction)

31
Q

Treatment of RVMI

A

Initially treated pretty much like others with acute MI with dual antiplatelets, statins, anticoagulation, urgent revascularization (thrombolytics or PCI).

Patients with RVMI require high preload to maintain adequate right heart output. Therefore, patients with hypotension and low/normal JVP should be given high flow IV fluids to increase RV preload (if JVP is high, fluids may not help as much)

Drugs that lower preload (Nitrates, diuretics, opioids) can cause profound hypotension and should be avoided. Look for tanking BP after nitrate administration.

Drugs that slow heart rate (B blockers) or lower contractility (CCBs) should be used with caution

32
Q

Primary effects of nitrates

A

They are vasodilators that dilate veins, arteriole, and coronary arteries by relaxing vascular smooth muscle cells.

Their primary anti-ischemic effects are due to SYSTEMIC vasodilation though rather than coronary vasodilation. Systemic venodilation lowers preload and LV EDV and reduces myocardial oxygen demand by reducing wall stress.

Can lower SVR and BP. The fall in systemic BP reduces wall stress, which leads to further decrease in oxygen demand.

33
Q

How should you manage patients with persistent tachyarrhythmias (narrow or wide complex) causing hemodynamic instability?

A

Immediate synchronized cardioversion bc of risk of rapid clinical deterioration

This involves the delivery of a low energy electric shock synchronized to the QRS complex. Whenever possible, give patients appropriate sedation and analgesia prior to cardioversion

34
Q

SVT

A

Regular, narrow complex tachycardia.

Can cause hemodynamic instability (hypotension, signs of shock, ischemic chest discomfort, mental status changes, acute pulmonary edema) and signs of poor perfusion (cool extremities)

Common causes are inappropriate sinus tachy, atrial tachy, atrial flutter, and AV nodal reentrant tachy

35
Q

Role of IV antiarrhythmics like amiodarone or procainamide in setting of tachycardia

A

For stable recurrent or refractory wide complex tachy.

These drugs can worsen hypotension and are not recommended acutely in patients with hypotension or hemodynamic instability

36
Q

Unsynchronized cardioversion

A

AKA defibrillation. Provides high energy shock at a random point in cardiac cycle. Used during resuscitation efforts in patients with pulseless cardiac arrest who have a shockable rhythm (VFib, Pulseless VTach).

In any other scenario, this can actually INDUCE VFib

37
Q

Presentation of worsening fatigue and irregular HR

A

AFib. 2 treatment issues in all patients with new onset AF

1) Choice btw rate and rhythm control (no real difference)
2) Risk stratification for prevention of systemic embolization. Use CHA2DS2-VASc score. 2 and up indicates oral anticoag.

38
Q

Role of amlodipine and HCTZ in AFib

A

None - they are antihypertensives

39
Q

Classification of angina

A

Classic

1) Typical location (substernal), quality (pressure) and duration (More than 20minutes)
2) Provoked by exercise/emotional upheaval
3) Relieved with nitroglycerin or rest

Atypical
1) 2 of 3 classic angina characteristics

Non-anginal
1) 0 or 1 of 3 classic angina characteristics

40
Q

Pretest probability of CAD

A

Low (less than 10%)

1) ASx patient of any age
2) Atypical CP in women less than 50

Intermediate (20-80%)

1) Atypical angina in men of all ages
2) Atypical angina in women starting at age 50
3) Typical angina in women 30-50

High (over 90%)

1) Typical angina in men at least 40
2) Typical angina in women at least 60

41
Q

Initial testing for patients with stable angina

A

Exercise ECG

Coronary angiography in patients with high risk findings on initial stress testing. OR in patients with high pretest probability of ischemic heart disease (AKA CAD)

42
Q

Cause of stable angina

A

myocardial oxygen demand exceeds oxygen supply. Symptoms typically gradual in onset with exertion and relieved by rest or termination of provoking activity

Look out for risk factors! For example, SLE is linked to accelerated atherosclerosis and premature CAD

Look out for atypical pain! Like burning epigastric pain not relieved by antacids.

43
Q

Risk factors/association for aortic dissection

A

1) HTN (Most common)
2) Marfan
3) Cocaine

44
Q

Clinical features of aortic dissection

A

1) Severe, sharp, tearing chest or back pain
2) More than 20 mmHg variation in systolic BP btw arms

It’s an intimal tear!

45
Q

Complications from aortic dissection

A

1) Stroke (carotid arteries or vertebral arteries)
2) Acute aortic regurgitation (aortic valves) - Retrograde extension of the intimal tear can involve the aortic valve and cause this. Patient can develop sudden worsening CP, hypotension, pulm edema along with early decrescendo diastolic murmur of AR. This is more with type A dissections (ascending aorta) that have 1-2% mortality per hour following symptom onset. Emergency surgical repair indicated.
3) Horner Syndrome (superior cervical sympathetic ganglion)
4) Acute myocardial ischemia/infarction (coronary artery)
5) Pericardial effusion/cardiac tamponade (pericardial cavity) - also usually ascending that propagates proximally
6) Hemothorax (pleural cavity)
7) Lower extremity weakness or ischemia (spinal or common iliac arteries)
8) Abdominal pain (mesenteric artery)

46
Q

Restrictive cardiomyopathy

A

Less common than dilated or hypertrophic. It may be caused by infiltrative diseases (sarcoid, amyloid), storage diseases (hemochromatosis), endomyocardial fibrosis or just be idiopathic. Hemochromatosis is a REVERSIBLE cause - phlebotomy. Amyloid treatment is supportive. Sarcoid and scleroderma treatment is steroids.

Present with primarily diastolic dysfunction (HFpEF)

LV volume is normal and wall thickness may be normal or symmetrically thickened. Symmetric thickening of the ventricle helps to differentiate restrictive from hypertrophic, in which the IV septum is thickest.

Signs of R HF are prominent - prominent JVD, bilateral ankle edema and tender hepatomegaly.

CAN cause signs of L HF as well like bibasilar crackles and pleural effusion.

47
Q

Bradycardia, AV block, Hypotension and diffuse wheezing

A

Suggets B-blocker OD.

Note: CCB, digoxin, and cholinergics can cause similar symptoms, but wheezing is more specific for BBlockers

Most common presentation is bradycardia and hypotension leading to cardiogenic shock (cold and clammy extremities). Other effects include hypoglycemia, bronchospasm (Beta 2 blockade), and neuro dysfunction (delirium, seizures)

48
Q

Management of B Blocker OD

A

First steps are to secure the airway and give isotonic fluid boluses and IV atropine for initial treatment of hypotension and bradycardia.

In patients with refractory or profound hypotension, the next step is to give IV glucagon. Glucagon increases intracellular levels of cAMP and has been effective in treating both beta blocker and CCB toxicity.

Other therapies that can be used simultaneously or in succession include IV Calcium, vasopressors (Epi or Norepi), high dose insulin and glucose, and IV lipid emulsion therapy

49
Q

Symptoms of digoxin toxicity

A

Cardiac - life threatening arrhythmias***

GI

1) Anorexia
2) N/v
3) Abdominal pain

Neuro

1) Fatigue
2) Confusion
3) Weakness
4) Color vision alterations***

Tx - Digoxin specific antibody (Fab)

50
Q

Wolff-Parkinson-White Syndrome

A

Normally, electrical impulses pass from atria to ventricles via AV node. In WPW there is an accessory pathway (Bundle of Kent) that directly connects the atria to the ventricles, bypassing the AV node. Antegrade conduction through this pathway with resultant preexcitation of the ventricles produces ECG features

1) Short PR segment. Usually less than 0.12s
2) Slurred and broad upstroke of QRS complex (delta wave)
3) QRS interval widening with ST/T wave changes

Most patients are ASx, BUT it can be associated with arrhythmias. If there is retrograde conduction from the ventricles to the atria, a re-entrant SVT may occur. ECG changes will not be as apparent during the SVT but the delta wave should be visible once rhythm is slowed. Sudden death can occur if WPW is untreated.

51
Q

Peripheral artery disease treatment

A

It is a CAD risk equivalent. Medical therapy should include aggressive risk factor modification with counseling for smoking cessation, lipid-lowering therapy and evaluation and treatment for HTN and DM

Start patient on low dose ASA and statins. Next step is to enroll patient in a supervised exercise program!

Exercise therapy for a minimum of 12w with 30-45min of exercise at least 3 times a week is recommended for all patients with claudication.

The goal is to reproduce the claudication symptoms during each session.

Supervised exercise programs have been shown in multiple trials to reduce symptoms and improve maximum walking distance in these patients.

Pharm tx with cilostazol and percutaneous or surgical revasculatization should be reserved for those with persistent symptoms despite adequate supervised exercise therapy.

52
Q

What must patients get if they’re on digoxin?

A

Routine blood drug level checks.

Digoxin is a cardiac glycoside used to treat AFib and HF and is renally cleared with a narrow therapeutic index. Toxicity presents as n/v, decreased appetite, confusion, and weakness. Patient can have visual symptoms like scotomata, blurry vision, color vision changes or blindness.

Inciting event like virus or excessive diuretic use can lead to volume depletion or renal injury that acutely elevates the digoxin level. This can lead to symptoms of toxicity in patient who are chronically on digoxin. Hypokalemia (often associated with loop diuretics) increases patient’s susceptibility to toxic effects of digoxin.

Any patient with these symptoms, get the level of the drug as well as ECG and PT/INR to rule out life threatening arrhythmias and coagulopathy

53
Q

CHF due to LV dysfunction

A

Characterized by decreased cardiac output/index (Index is CO divided by body surface area), increased SVR, and an increase in LV EDV.

Can cause mitral valve regurgitation as a result of mitral annulus enlargement with LV dilatation and/or papillary muscle displacement due to LV remodeling.

Can cause secondary RV dysfunction

54
Q

Nitroprusside toxicity

A

Often used in hypertensive emergency. It is a parenteral vasodilator with quick onset and offset of action and is commonly used for rapid BP correction in patients with hypertensive emergency.

Metabolism of nitroprusside releases NO and CN. NO induces arteriolar and venous vasodilation.

Cyanide toxicity can occur in patients getting prolonged infusions or higher doses and is most common in patients with renal insufficiency!!. It features AMS, lactic acidosis, seizures, and coma.

55
Q

Hypertensive emergency BP correction

A

Don’t go too fast. This might cause cerebral ischemia with AMS and/or generalized seizures.

MAP should be lowered by 10-20% in the first hour and by another 5-15% over the next 23hrs.

56
Q

Most effective BP intervention

A

Weight loss in obese patients. In non-obese patients it is DASH Diet.

Always do an adequate trial of nonpharm therapy or lifestyle mods before using antihypertensive drugs.

57
Q

Definition of HTN

A

Systolic BP over 140 and/or diastolic BP over 90. Based on average of 2 or more properly measured readings at 2 or more visits after initial screening.

58
Q

Tachycardia-mediated cardiomyopathy

A

Typical presentation is a patient with progressive dyspnea, decreased exercise tolerance, AFib with RVR and LV systolic dysfunction.

Many tachyarrhythmias with prolonged periods of rapid ventricular rates can lead to tachycardia-mediated cardiomyopathy. These are AFib, AFlutter, VTach, Incessant atrial/junctional tachy, and AV nodal reentrant tachy. Chronic tachy causes structural changes in the heart including LV dilatation and myocardial dysfunction.

Most patients have palpitations and/or signs of CHF. Dx requries echo, ECG, and assessment for other causes of LV dysfunction including CAD, esp in patients with symptoms or risk factors suggestive of CAD.

Treatment includes aggressive rate control or restoration of normal sinus rhythm due to potential reversibility of tachy-mediated cardiomyopathy and normalization of LV systolic function.

Therapy options include AV nodal blocking agents, antiarrhythmic drugs, and catheter ablation of arrhythmia

59
Q

Conditions associated with AFib

A

Cardiac

1) Hypertensive heart disease (most common)
2) CAD
3) Rheumatic/Valvular heart disease (mitral stenosis, mitral regurgitation)
4) CHF
5) Hypertrophic cardiomyopathy
6) Congenital heart disease (ASD)
7) Post cardiac surgery

Pulm

1) OSA
2) Pulm embolism
3) COPD
4) Acute hypoxia (pneumonia)

Misc

1) Obesity
2) Endocrine (hyperthyroid!!, diabetes)
3) Alcohol abuse
4) Drugs (amphetamines, cocaine, theophylline)

All patients with new onset AFib should have TSH and free T4 checked.

60
Q

Strongest predictor of stent thrombosis after intracoronary stent implantation

A

Premature discontinuation of antiplatelet therapy (med noncompliance)

61
Q

Stent thrombosis

A

Potentially fatal complications of coronary artery stenting. long-term dual antiplatelet therapy with ASA and platelet P2Y12 receptor blocker (clopidogrel, prasurgel, ticagrelor) is recommended to reduce risk of stent thrombosis after intracoronary drug-eluting stent placement

Premature D/C-ing of antiplatelet therapy is strongest predicator in the first 12 months and all patients should be screened for, and counseled regarding, med compliance to reduce risk.

62
Q

What meds can cause bronchoconstriction in patients with asthma?

A

ASA - esp in patients with concurrent chronic rhinitis and nasal polyps.

B-blockers - nonselective blockers (propranolol, nadolol, sotalol, timolol) act on B1 and B2 and often trigger constriction in patients with asthma. Cardioselective (metoprolol, atenolol, bisoprolol, nebivolol) act on B1 mostly and are generally safe in patients with mild to moderate asthma, but ALL B blockers can trigger bronchoconstriction esp when at high doses.

ACE inhibs (lisinopril) can cause dry cough through increased levels of circulating bradykinin and resultant bronchial irritation. Can be immediate or delayed by months. BUT this is NOT affected by asthma.

63
Q

High dose niacin therapy side effect

A

Cutaneous flushing and pruritus. Explained by prostaglandin-induced peripheral vasodilation and can be reduced by low dose ASA

64
Q

Indications for carotid endarterectomy

A

Men

1) Asx - 60-99% stenosis
2) Sx - 50-69% (Grade 2A), 70-99% (Grade 1A)

Women
1) Both Asx and Sx - 70-99% stenosis

Lesions less than 50% are typically monitored with annual Duplex US. Surgery is not indicated at this stage and patients are medically managed with pharmacotherapy (antiplatelet, statins) and risk factor optimization (tobacco cessation, DM and HTN control)

65
Q

Tx of infective endocarditis

A

Tailored to specific causative organism as soon as they are identified. Most viridans group strep (like mutans) are highly susceptible to penicillin and should be treated with IV aqueous penicillin G or IV ceftriaxone for 4w. Ceftriaxone is easier to give at home due to once daily dosing.

Presentation is intermittent fever, fatigue, new holosystolic murmur, and positive blood culture.

Start with empiric vancomycin to cover staph (Methicillin sensitive and resistant), strep and enterococci after getting the blood cultures.

66
Q

Medical therapy shown to improve morbidity and mortality in patients with known CAD

A

1) DAPT with ASA and P2y12 receptor blockers (clopidogrel, prasugrel, ticagrelor)
2) Beta blockers
3) ACE inhib or ARBs
4) HMG-CoA Reductase Inhibitors (statins)
5) Aldosterone antagonists (spironolactone, eplerenone) in patients with LV EF less than or equal to 40 who have HF symptoms or diabetes